1 / 65

Medical Management of Stroke

Medical Management of Stroke. Stroke Code!. Rapid Assessment. (NIH Stroke Scale) Non-con CT CTA/CTP Call Duty Neurologist Is patient t-PA candidate? Or candidate for other acute therapies? See Neurology Sharepoint for Stroke Protocols Stroke registry Stroke review meetings.

leal
Télécharger la présentation

Medical Management of Stroke

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Medical Management of Stroke

  2. Stroke Code! • Rapid Assessment. (NIH Stroke Scale) • Non-con CT • CTA/CTP • Call Duty Neurologist • Is patient t-PA candidate? • Or candidate for other acute therapies? • See Neurology Sharepoint for Stroke Protocols • Stroke registry • Stroke review meetings

  3. Stroke Definitions • Focal Neurologic • Negative Symptoms • Vascular Origin • Sudden Onset • Sudden Headache (SAH)

  4. Cerebral Blood Flow • Normal CBF 50 – 55 ml/100gm/min • About 18 - 20 ml/100gm/min – Failure of neuronal function • About 8 -10 ml/100gm/min – cellular death • Hypoperfused area = ischemic penumbra • Restore perfusion to ischemic penumbra • Protect neurons until perfusion restored • Rapid Diagnosis and intervention

  5. Transient Ischemic Attack • < 24 hours by definition • Most last 10 – 20 minutes • Warning sign of Stroke: like unstable angina and MI • Expedite work-up • Typically present with rapid-onset deficits maximal at onset. • Compare with “march” of Migraine or Seizure

  6. Signs of TIA • Anterior circulation • Aphasia, neglect, Amaurosis, isolated leg weakeness, abulia • Posterior circulation • Diplopia, ataxia, dysphagia,hiccups, vertigo, crossed signs • Either • Hemiplegia, visual field cuts, hemisensory loss, dysarthria

  7. TIA evaluation • Carotid imaging • Intracranial vessel imaging • Cardiac source eval

  8. TIA Rx • CEA for symptomatic Carotid Stenosis >70% • Stenting, if surgical contraindications • Cardiac source: Coumadin. ASA if not able to give coumadin. • Atherosclerosis: ASA, Statins, Clopidogrel. ASA + dipyridimole • Lacunar: ~ Same. Antihypertensive Rx.

  9. MATCH Trial • Management of Atherothrombosis with Clopidogrel in High-Risk Patients with Recent Transient Ischemic Attack (MATCH) study, • Clopidogrel + aspirin for secondary prevention of stroke • The efficacy of any antiplatelet therapy, including aspirin, is modest when it is used as monotherapy, and combination therapy with 2 antiplatelet agents has shown promise in reducing the risk for secondary stroke in patients who have had a previous transient ischemic attack (TIA) or ischemic stroke. • MATCH trial indicated that the reduction in risk achieved by adding aspirin to clopidogrel is not significantly greater than that achieved with clopidogrel alone. • Significant increase in life-threatening bleeding complications was associated with the combination of clopidogrel + aspirin. • Clopidogrel + aspirin cannot be recommended at this time for the secondary prevention of stroke in patients who have had a previous ischemic stroke or TIA. • (? 3 month short term Rx after ominous stroke) • From American Journal of Medicine

  10. ESPS-2 • Second European Stroke Prevention Study (ESPS-2) • Demonstrated a significant reduction in risk for secondary stroke with aspirin + extended-release dipyridamole versus aspirin alone

  11. PRoFESS Trial(Full results yet to be published) • Prevention Regimen for Effectively avoiding Second Strokes. • Plavix (clopidogrel) ~= Aggrenox (ASA + DP) • (Micardis not better than Placebo)

  12. CT scan of early stroke

  13. Types of Stroke • Ischemic • Arterial • Venous • Headache, lethargy, Seizure • Hemorrhagic • Intra-parenchymal • Sub-arachnoid

  14. Stroke etiologies

  15. Stroke risks

  16. Ischemic Stroke • Destructive cascade induced by ischemia • Decreased O2 and glucose • ATP insufficiency • Ca++ influx • Increase Glutamate • Membrane degradation • Free radical increase • Apotosis

  17. Large MCA Stroke

  18. Sources of stroke

  19. Stroke Syndromes • Carotid • ACA: Leg > Arm, Frontal lobe symptoms • MCA: Face, Arm > Leg; gaze preference, Aphasia, hemineglect etc • Vertebrobasilar • PCA: Hemianopsia, etc • Brain stem Stroke: Crossed signs, diplopia, vertigo, dysphagia, Horner’s Syndrome, etc

  20. Right PICA stroke

  21. Lacunar Syndromes • Pure Motor • Pure Sensory • Sensorimotor • Ataxia-hemiparesis • Dysarthria Clumsy Hand • Hemichorea

  22. Arteriopathies • Atherosclerosis • Non-Atherosclerotic • Inflamatory • Angiitis • GCA • Syphilis etc • Non-inflamatory • Dissection • FMD • Moya Moya • Homocysteinuria • CADASIL • cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy • Drugs etc

  23. Age Race Gender Family History Prior Stroke HTN DM Heart Disease Smoking Hyperlipidemia Carotid bruits Excessive EtOH BCP Obesity and inactivity Stroke Risk Factors

  24. Embolic Stroke • High Risk vs Low Risk Cardiac sources

  25. Hematological Diseases • Antiphospholipid Antibody Syndrome • Protein C deficiency • Protien S deficiency • Factor V Leiden • Other hypercoagulable states

  26. Venous Ischemic Stroke • Post partum • Hypercoagulable States • Infections • Dehydration • Tumors • Post-op

  27. Hemorrhagic Strokes • Hypertensive • Putamen • Thalamus • Cerebellar • Pontine • Aneurysmal • AVM • Amyloid Angiopathy

  28. Stroke Rx decision tree

  29. Ischemic Stroke Strategies • “Time is Brain” • Reperfusion • Ancillary Care • Systemic • Avoid Complications • Neuro-protection • Secondary Prevention • Anti-platelet agents • Statins • Hypertension Rx • Smoking cessation • Weight Control

  30. Initial Stabilization and Monitoring • Assess airway maintenance • Level of Arousal • Evaluation for MI • Dysrhythmia monitoring

  31. Diagnostic Eval for Stroke • Urgent, for all: CT or MRI, Electrolytes, glucose, BUN, Creatinine, CBC, PT/PTT, O2 Sat • Urgent, for some: Tox screen, Blood alcohol, LFTs, HCG, CXR, ABG, LP, EEG • Non-urgent, for etiologic eval: TEE or TTE, Carotid Doppler, MR angiogram, CT angiogram, Catheter angiogram, RPR, ESR, homocysteine, lipids. • Selected patient eval: Coag panel, TSH, MR imaging and MRA of intracranial vessels

  32. Stroke Rx • Anticoagulation ~doesn’t benefit • Consider anticoagulation • Known large vessel disease with fluctuating symptoms • Mechanical Heart valves • LV Thrombus • Prothrombotic states • Cerebral Venous Thrombosis • Prone to Hemorrhage: • Large infarcts • Extensive Occipital Lobe involvement • Early Petechial Conversion • Uncontolled hypertension, Hyperglycemia

  33. Stroke Rx • Induced hypertension might help salvage ischemic Penumbra • Double edge sword

  34. Fluid management • May need to be NPO • Avoid hypotonic solutions if risk of cerebral edema • Monitor electrolytes • Prevent hyperglycemia – leads to worse outcome

  35. Prevent Complications • DVT prophylaxis • Pneumatic compression stockings • SQ Low Molecular Weight Heparin • GI Prophylaxis • Feeding • Chest PT/positioning • Stool softeners • Prevent infection - UTI

  36. MRIs before and after t-PA

  37. Thrombolytic Therapy • Goal – preserve ischemic penumbra • 3 hour window for IV t-PA • 6% bleed. • Outcome: 12 % > placebo • Intra-arterial t-PA – not FDA approved – “investigational”, 6 hour window. • Abciximab – disappointing result • ASA acute Rx – some value • Hypothermia – shows promise, but technically difficult • “Merci” clot retriever – FDA approved

  38. Absolute contraindications to t-PA • Presenting symptoms and signs should not suggest acute subarachnoid hemorrhage • Head trauma or prior stroke within the previous 3 months • Myocardial infarction within the previous 3 months • Gastrointestinal or urinary tract hemorrhage within the previous 21 days • Major surgery within the previous 14 days • Arterial puncture at a noncompressible site within the previous 7 days • History of previous intracranial hemorrhage • Active bleeding or acute trauma (fracture) on examination • Platelet count <100,000 mm3 • Blood glucose <50 mg/dL • Seizure or postictal neurologic impairments

  39. Relative contraindications to t-PA • Oral anticoagulation (international normalized ratio must be ≤1.5) • Heparin within the previous 48 hours (activated partial thromboplastin time must be in the normal range)

  40. Stroke with hemorrhage s/p t-PA

  41. Protocol for thrombolytic therapy in patients with of acute ischemic stroke • 1. Determine if the patient is a candidate for thrombolytic therapy. • 2. Infuse alteplase (rt-PA) 0.9 mg/kg (maximum of 90 mg) over 60 minutes with 10% of the dose given as a bolus over 1 minute. • 3. Admit the patient to an intensive care unit or stroke unit for monitoring. • 4. Neurologic assessment to be performed every 15 minutes during the infusion of rt-PA and every 30 minutes for the first 2 hours for the next 6 hours, then every hour for 24 hours from the time of initial treatment. • 5. If the patient develops a severe headache, acute hypertension, nausea, or vomiting, discontinue the infusion and perform and emergency CT brain scan. • 6. Measure blood pressure every 15 minutes for the first 2 hours, every 30 minutes for the next 6 hours, and then every hour until 24 hours from the time of initial treatment. • 7. Increase the frequency of blood pressure measurements if a systolic blood pressure ≥180 mm Hg systolic or ≥105 mm Hg diastolic is recorded. Administer antihypertensive medications to maintain the blood pressure at or below these levels

  42. Antihypertensive Rx in acute stroke • Avoid Rx unless planned thombolysis and SBP > 185 or DBP >110 • Evidence of end organ damage • Excessively high BP: SBP > 220 ; DBP > 110 • Labetolol or Nicardipine Drip for BP Rx with thombolysis

  43. Antihypertensive Rx

  44. Vasopressor Rx

  45. Massive stoke with trans-falcine herniation

  46. Cerebral Edema Rx • First prevention • Higher risk • Large hemispheric stroke in younger person (little room to swell) • Cerebellar Stroke • H/o Hypertension

  47. Cerebral Edema Rx • HOB elevation, Fluid restriction, Treat fever • Hyperventilation – causes vasoconstriction: brief effect, may get rebound vasodilation, ?worsens ischemia • Osmotic agents – mannitol vs hypertonic saline vs furosemide • Barbiturates – decrease cerebral metabolic rate. Not really effective. • Steroids do not work for cytotoxic stroke edema • Hypothermic Rx? • Hemicranectomy/Surgical Decompression

  48. Large stroke s/p hemicraniectomy

  49. Hemorrhagic Stroke Strategies • Stop Bleeding • Ancillary Support • Neuro-protection

  50. Parenchymal Hemorrhage in Basal Ganglia

More Related